141 related articles for article (PubMed ID: 28726391)
21. 'Polymorphism-aided' Selective Targeting and Inhibition of Caspase-6 by a Novel Allosteric Inhibitor Towards Efficient Alzheimer's Disease Treatment.
Kumi RO; Agoni C; Issahaku AR; Olotu FA; Soliman MES
Cell Biochem Biophys; 2020 Sep; 78(3):291-299. PubMed ID: 32592127
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of the caspase-like catalytic domain of human paracaspase.
Snipas SJ; Wildfang E; Nazif T; Christensen L; Boatright KM; Bogyo M; Stennicke HR; Salvesen GS
Biol Chem; 2004 Nov; 385(11):1093-8. PubMed ID: 15576331
[TBL] [Abstract][Full Text] [Related]
23. Proteolytic cleavage of Livin (ML-IAP) in apoptotic melanoma cells potentially mediated by a non-canonical caspase.
Yan H; Brouha B; Liu T; Raj D; Biddle D; Lee R; Grossman D
J Dermatol Sci; 2006 Sep; 43(3):189-200. PubMed ID: 16806840
[TBL] [Abstract][Full Text] [Related]
24. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ
Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396
[TBL] [Abstract][Full Text] [Related]
25. Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells.
Nyormoi O; Wang Z; Doan D; Ruiz M; McConkey D; Bar-Eli M
Mol Cell Biol; 2001 Aug; 21(15):4856-67. PubMed ID: 11438643
[TBL] [Abstract][Full Text] [Related]
26. Caspase-6 and neurodegeneration.
Graham RK; Ehrnhoefer DE; Hayden MR
Trends Neurosci; 2011 Dec; 34(12):646-56. PubMed ID: 22018804
[TBL] [Abstract][Full Text] [Related]
27. Requirement for Serine-384 in Caspase-2 processing and activity.
Zamaraev AV; Volik PI; Nilov DK; Turkina MV; Egorshina AY; Gorbunova AS; Iarovenko SI; Zhivotovsky B; Kopeina GS
Cell Death Dis; 2020 Oct; 11(10):825. PubMed ID: 33011746
[TBL] [Abstract][Full Text] [Related]
28. Specific inhibition of caspase-3 by a competitive DARPin: molecular mimicry between native and designed inhibitors.
Schroeder T; Barandun J; Flütsch A; Briand C; Mittl PR; Grütter MG
Structure; 2013 Feb; 21(2):277-89. PubMed ID: 23333429
[TBL] [Abstract][Full Text] [Related]
29. Activation and regulation of caspase-6 and its role in neurodegenerative diseases.
Wang XJ; Cao Q; Zhang Y; Su XD
Annu Rev Pharmacol Toxicol; 2015; 55():553-72. PubMed ID: 25340928
[TBL] [Abstract][Full Text] [Related]
30. Reprogramming Caspase-7 Specificity by Regio-Specific Mutations and Selection Provides Alternate Solutions for Substrate Recognition.
Hill ME; MacPherson DJ; Wu P; Julien O; Wells JA; Hardy JA
ACS Chem Biol; 2016 Jun; 11(6):1603-12. PubMed ID: 27032039
[TBL] [Abstract][Full Text] [Related]
31. Vasculogenic mimicry: Possible role of effector caspase-3, caspase-6 and caspase-7.
Linder M; Tschernig T
Ann Anat; 2016 Mar; 204():114-7. PubMed ID: 26704356
[TBL] [Abstract][Full Text] [Related]
32. Interactome network analysis identifies multiple caspase-6 interactors involved in the pathogenesis of HD.
Riechers SP; Butland S; Deng Y; Skotte N; Ehrnhoefer DE; Russ J; Laine J; Laroche M; Pouladi MA; Wanker EE; Hayden MR; Graham RK
Hum Mol Genet; 2016 Apr; 25(8):1600-18. PubMed ID: 26908611
[TBL] [Abstract][Full Text] [Related]
33. Alternatively spliced caspase-6B isoform inhibits the activation of caspase-6A.
Lee AW; Champagne N; Wang X; Su XD; Goodyer C; Leblanc AC
J Biol Chem; 2010 Oct; 285(42):31974-84. PubMed ID: 20682790
[TBL] [Abstract][Full Text] [Related]
34. The effect of direct translocation across endosomes on the cytotoxicity of the recombinant protein e23sFv-Fdt-casp6 to HER2 positive gastric cancer cells.
Ren JL; Meng YL; Hu B; Jia LT; Zhang R; Xu YM; Xie QS; Zhang YQ; Jin BQ; Chen SY; Wang T; Yang AG
Biomaterials; 2011 Oct; 32(30):7641-50. PubMed ID: 21767874
[TBL] [Abstract][Full Text] [Related]
35. Sox11 Reduces Caspase-6 Cleavage and Activity.
Waldron-Roby E; Hoerauf J; Arbez N; Zhu S; Kulcsar K; Ross CA
PLoS One; 2015; 10(10):e0141439. PubMed ID: 26505998
[TBL] [Abstract][Full Text] [Related]
36. Structural determinants of MALT1 protease activity.
Wiesmann C; Leder L; Blank J; Bernardi A; Melkko S; Decock A; D'Arcy A; Villard F; Erbel P; Hughes N; Freuler F; Nikolay R; Alves J; Bornancin F; Renatus M
J Mol Biol; 2012 May; 419(1-2):4-21. PubMed ID: 22366302
[TBL] [Abstract][Full Text] [Related]
37. Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation.
Kaushal V; Dye R; Pakavathkumar P; Foveau B; Flores J; Hyman B; Ghetti B; Koller BH; LeBlanc AC
Cell Death Differ; 2015 Oct; 22(10):1676-86. PubMed ID: 25744023
[TBL] [Abstract][Full Text] [Related]
38. Substrate-induced conformational changes occur in all cleaved forms of caspase-6.
Vaidya S; Velázquez-Delgado EM; Abbruzzese G; Hardy JA
J Mol Biol; 2011 Feb; 406(1):75-91. PubMed ID: 21111746
[TBL] [Abstract][Full Text] [Related]
39. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
Wang J; Zheng L; Lobito A; Chan FK; Dale J; Sneller M; Yao X; Puck JM; Straus SE; Lenardo MJ
Cell; 1999 Jul; 98(1):47-58. PubMed ID: 10412980
[TBL] [Abstract][Full Text] [Related]
40. Mutational analysis of CASP1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 14 genes in gastrointestinal stromal tumors.
Kim YR; Kim KM; Yoo NJ; Lee SH
Hum Pathol; 2009 Jun; 40(6):868-71. PubMed ID: 19269008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
